Phase IB study of low-dose intraperitoneal recombinant Interleukin-2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report
Uziel Beller, Abraham Chachoua, James L. Speyer, Joan Sorich, Margaret Dugan, Leonard Liebes, Roberta Hayes, E.Mark BeckmanVolume:
34
Year:
1989
Language:
english
DOI:
10.1016/0090-8258(89)90182-0
File:
PDF, 602 KB
english, 1989